Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bifidobacterium longum for treating obesity and associated metabolic disorders

Bifidobacterium longum for treating obesity and associated metabolic disorders

US Patent 10973862 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bifidobacterium longum NCIMB 416762025
Bifidobacterium longum NCIMB 416762023
Bifidobacterium longum able to beneficially modulate immune response to respirat2023
Bifidobacterium longum able to beneficially modulate immune response to respirat2022
Lactobacillus casei for treating obesity and associated metabolic disorders2022
Lactobacillus casei for treating obesity and associated metabolic disorders2022
Lactobacillus casei for treating obesity and associated metabolic disorders2022
Combination product for prophylaxis and treatment of irritable bowel syndrome2022
Combination product for prophylaxis and treatment of irritable bowel syndrome2022
Probiotic Bifidobacterium strain2022
Probiotic Bifidobacterium strain2022
Bifidobacterium longum NCIMB 416762020